Harrow, Inc. Proceeds from (Repayments of) Related Party Debt
Harrow, Inc. (HROW) reported Proceeds from (Repayments of) Related Party Debt of $27.54 thousand for the 188-month period ending 2014-03-31, per its 10-Q filed 2014-05-15.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt · last filed 2014-05-15
- Harrow, Inc. proceeds from (repayments of) related party debt for the quarter ending 2013-03-31 was $0.00.
- Harrow, Inc. proceeds from (repayments of) related party debt for the quarter ending 2012-03-31 was $0.00.
- Harrow, Inc. proceeds from (repayments of) related party debt for the quarter ending 2011-03-31 was $0.00.
- Harrow, Inc. proceeds from (repayments of) related party debt for fiscal 2012 was $0.00, a 100.00% decline from fiscal 2011.
- Harrow, Inc. proceeds from (repayments of) related party debt for fiscal 2011 was $254.14K.
- Harrow, Inc. proceeds from (repayments of) related party debt for fiscal 2010 was $0.00.
| Period end | Proceeds from (Repayments of) Related Party Debt 3 month | Proceeds from (Repayments of) Related Party Debt 12 month | Proceeds from (Repayments of) Related Party Debt 161 month | Proceeds from (Repayments of) Related Party Debt 164 month | Proceeds from (Repayments of) Related Party Debt 167 month | Proceeds from (Repayments of) Related Party Debt 170 month | Proceeds from (Repayments of) Related Party Debt 173 month | Proceeds from (Repayments of) Related Party Debt 176 month | Proceeds from (Repayments of) Related Party Debt 182 month | Proceeds from (Repayments of) Related Party Debt 185 month | Proceeds from (Repayments of) Related Party Debt 188 month |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-03-31 | $27.54K 10-Q · filed 2014-05-15 | ||||||||||
| 2013-12-31 | $254.14K 10-K · filed 2014-03-28 | ||||||||||
| 2013-09-30 | $254.14K 10-Q · filed 2013-11-06 | ||||||||||
| 2013-06-30 | $254.14K 10-Q · filed 2013-08-14 | ||||||||||
| 2013-03-31 | $0.00 10-Q · filed 2013-05-08 | $254.14K 10-Q · filed 2013-05-08 | |||||||||
| 2012-12-31 | $0.00 10-K · filed 2013-03-18 | $254.14K 10-K · filed 2013-03-18 | |||||||||
| 2012-09-30 | $254.14K 10-Q · filed 2012-11-14 | ||||||||||
| 2012-06-30 | $254.14K 10-Q · filed 2012-08-14 | ||||||||||
| 2012-03-31 | $0.00 10-Q · filed 2013-05-08 | $254.14K 10-Q · filed 2012-05-10 | |||||||||
| 2011-12-31 | $254.14K 10-K · filed 2013-03-18 | $254.14K 10-K · filed 2012-02-23 | |||||||||
| 2011-03-31 | $0.00 10-Q · filed 2012-05-10 | ||||||||||
| 2010-12-31 | $0.00 10-K · filed 2012-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |